Empowering CML Caregivers: Strategies and Support Systems

Opinion
Video

Experts on chronic myeloid leukemia discuss how caregivers can collaborate with the health care team and support newly diagnosed patients.

This program was made possible with support from Novartis Pharmaceuticals.

Video content above is prompted by the following questions:

  • In your work with caregivers, how have you seen them collaborate with the healthcare team to support newly diagnosed patients with CML?
    • Are there any specific aspects of CML management where caregiver support is particularly impactful?
    • Are there any resources or support groups you recommend for caregivers of patients with CML?
Recent Videos
The medical characteristics of a patient may heavily factor into the selection of tyrosine kinase inhibition for the treatment of chronic myeloid leukemia.
The toxicity profile of interferon and the limited availability of transplantation established a need for TKI development for chronic myeloid leukemia.
4 experts in this video
4 experts in this video
4 experts in this video
4 experts in this video
4 experts in this video
We have the current CAR [T-cell therapies], which target CD19; however, we need others.
4 experts in this video
4 experts in this video
Related Content